Ohio Bans Telemedicine Abortion Pill Prescriptions

By Quinn Weimer | January 27, 2021 | 11:44am EST
(Getty Images)
(Getty Images)

(CNS News) -- Ohio Governor Mike DeWine (R) signed Senate Bill 260, sponsored by Senator Steve Huffman (R), into law on January 9. The new law bans abortion pill prescriptions from being made via telemedicine.

The bill states, “No physician shall personally furnish or otherwise provide an abortion-inducing drug to a pregnant woman unless the physician is physically present at the location where the initial dose of the drug or regimen of drugs is consumed at the time the initial dose is consumed.”

In response to when Bill 260 passed in the Ohio Senate on March 4, 2020, abortion provider Planned Parenthood released a statement which said, "Telemedicine is a safe way to expand access to people who may live far away from a surgical abortion health center. The bill would cut off access to safe, legal abortion for patients who currently have a hard time accessing a health care provider.”

(Getty Images)
(Getty Images)

“Ohio legislators should not be in the business of taking health care away from its citizens, and instead, focus on expanding access to reproductive health care,” said Planned Parenthood.

“As the proportion of chemically-induced abortion continues to increase, greater care – not less – ought to be exercised in ensuring women’s safety,” said Ohio Right to Life Vice President Stephanie Krider in a March 2020 press release.

“While it is too late for the unborn baby on whom the effects of this drug will be almost certainly fatal, using telemedicine to dispense dangerous, abortion-inducing drugs, as Planned Parenthood is already doing in Ohio, shows the abortion industry’s lack of regard for the danger it poses their patients," said Krider. "It is unacceptable to compromise patient safety for the convenience of the industry.”

Ohio's Republican Gov. Mike DeWine.  (Getty Images)
Ohio's Republican Gov. Mike DeWine. (Screenshot)

“The first pill in the chemical abortion pill regimen, mifepristone, is highly regulated by the FDA due to safety concerns,” said Ohio Right to Life. “The FDA recorded nearly 4,200 adverse events from mifepristone between 2012 and 2018 and over 1,000 of those cases required hospitalization. Since the abortion pill regimen was first introduced in the U.S. in 2000, 24 women have died from chemical abortion complications.”

MRC Store